Nuveen Asset Management LLC Acquires 59,190 Shares of U.S. Physical Therapy, Inc. (NYSE:USPH)

Nuveen Asset Management LLC boosted its position in U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 95.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 120,893 shares of the company's stock after acquiring an additional 59,190 shares during the quarter. Nuveen Asset Management LLC owned 0.80% of U.S. Physical Therapy worth $10,724,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in USPH. Lazard Asset Management LLC acquired a new stake in U.S. Physical Therapy in the fourth quarter valued at $84,000. Wells Fargo & Company MN grew its stake in shares of U.S. Physical Therapy by 2.2% in the fourth quarter. Wells Fargo & Company MN now owns 112,959 shares of the company's stock valued at $10,021,000 after buying an additional 2,465 shares in the last quarter. Deutsche Bank AG boosted its position in U.S. Physical Therapy by 49.3% in the 4th quarter. Deutsche Bank AG now owns 13,176 shares of the company's stock valued at $1,169,000 after buying an additional 4,350 shares during the last quarter. PNC Financial Services Group Inc. grew its position in shares of U.S. Physical Therapy by 37.4% during the fourth quarter. PNC Financial Services Group Inc. now owns 4,605 shares of the company's stock worth $409,000 after buying an additional 1,254 shares in the last quarter. Finally, Copeland Capital Management LLC raised its stake in U.S. Physical Therapy by 9.5% during the fourth quarter. Copeland Capital Management LLC now owns 839,356 shares of the company's stock valued at $74,459,000 after buying an additional 72,715 shares in the last quarter.

U.S. Physical Therapy Trading Down 0.9%

USPH stock traded down $0.71 during midday trading on Friday, hitting $74.89. The stock had a trading volume of 94,708 shares, compared to its average volume of 112,098. U.S. Physical Therapy, Inc. has a 1-year low of $62.77 and a 1-year high of $102.89. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.27. The business has a fifty day moving average price of $72.02 and a two-hundred day moving average price of $82.59. The firm has a market cap of $1.14 billion, a P/E ratio of 79.67, a price-to-earnings-growth ratio of 3.54 and a beta of 1.44.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last issued its quarterly earnings data on Wednesday, May 7th. The company reported $0.48 EPS for the quarter, topping the consensus estimate of $0.46 by $0.02. The firm had revenue of $183.79 million during the quarter, compared to the consensus estimate of $176.78 million. U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. The company's quarterly revenue was up 18.0% compared to the same quarter last year. During the same period in the prior year, the business posted $0.51 earnings per share. On average, sell-side analysts predict that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current fiscal year.

U.S. Physical Therapy Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, June 13th. Shareholders of record on Friday, May 23rd will be paid a $0.45 dividend. The ex-dividend date is Friday, May 23rd. This represents a $1.80 annualized dividend and a yield of 2.40%. U.S. Physical Therapy's dividend payout ratio is currently 82.57%.

Insider Activity at U.S. Physical Therapy

In other U.S. Physical Therapy news, COO Graham D. Reeve sold 1,730 shares of the stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $82.11, for a total value of $142,050.30. Following the completion of the sale, the chief operating officer now owns 7,168 shares in the company, valued at approximately $588,564.48. This trade represents a 19.44% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. 2.00% of the stock is owned by corporate insiders.

Analyst Ratings Changes

A number of research analysts recently commented on the stock. JPMorgan Chase & Co. lowered their price objective on shares of U.S. Physical Therapy from $120.00 to $110.00 and set an "overweight" rating on the stock in a research note on Wednesday, March 19th. Barrington Research dropped their price target on shares of U.S. Physical Therapy from $108.00 to $98.00 and set an "outperform" rating on the stock in a research report on Friday, February 28th. JMP Securities reiterated a "market outperform" rating and issued a $113.00 target price on shares of U.S. Physical Therapy in a research note on Tuesday, April 22nd. Wall Street Zen upgraded U.S. Physical Therapy from a "sell" rating to a "hold" rating in a research report on Thursday, May 8th. Finally, William Blair restated a "market perform" rating on shares of U.S. Physical Therapy in a research report on Thursday, February 27th. Two investment analysts have rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $109.00.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.